Quantitative Forensic Analysis of Opiates, Opioids, and Their Metabolites in Human Urine Without Hydrolysis

Applications | 2016 | Thermo Fisher ScientificInstrumentation
Sample Preparation, LC/MS, LC/MS/MS, LC/QQQ
Industries
Forensics
Manufacturer
Thermo Fisher Scientific

Summary

Significance of the Topic


This work addresses a major bottleneck in forensic toxicology: the lengthy hydrolysis step traditionally required for quantifying opiates, opioids and their conjugated metabolites in urine. Eliminating hydrolysis accelerates turnaround time, reduces sample handling errors and lowers analytical costs while maintaining robust sensitivity and specificity.

Objectives and Study Overview


The primary goal was to develop a fully quantitative, high-throughput method for intact conjugated metabolites of 19 opiates and opioids within human urine. Key aims included:
  • Removing the hydrolysis step to shorten preparation time.
  • Achieving low limits of quantitation for parent drugs and glucuronide metabolites.
  • Ensuring accuracy, precision and minimal carryover across a broad calibration range (5–500 ng/mL).

Methodology and Instrumentation


Sample preparation involved two-fold dilution of drug-free urine with water/methanol (95:5) spiked with 10 deuterated internal standards at 50 ng/mL. A 50 μL aliquot was injected at 27 °C.
Key instrumental components:
  • Prelude SPLC system for on-line sample cleanup and chromatographic separation.
  • Accucore aQ column (100 × 2.1 mm, 2.6 μm).
  • Gradient elution with 0.1% formic acid in water (A) and methanol (B) over 4.25 min.
  • TSQ Endura triple quadrupole mass spectrometer with HESI II source in positive SRM mode.

Results and Discussion


The method delivered:
  • Precision (%RSD) ≤20% at the LLOQ and low QC and ≤15% for higher levels.
  • Accuracy within ±20% at the LLOQ and low QC and within ±15% elsewhere.
  • Negligible carryover (<20% of LLOQ signal) and stable responses after 24 h at 4 °C.
  • Baseline resolution of all isobaric compounds in a 4.25-min run.
Representative chromatograms confirmed retention time reproducibility and absence of interference.

Benefits and Practical Application


This method offers forensic and clinical laboratories:
  • Substantial reduction in sample preparation time (removal of 18–24 h hydrolysis).
  • High throughput with a 4.25 min analysis per sample.
  • Cost savings from reagent and labor reduction.
  • Reliable quantitation of glucuronide conjugates without enzymatic hydrolysis.

Future Trends and Possibilities


Emerging directions may include:
  • Further automation of sample introduction to support large-scale casework.
  • Integration with high-resolution MS for expanded metabolite panels.
  • Miniaturized or ambient ionization techniques to reduce solvent use.
  • Application to alternative matrices (e.g., oral fluid, dried blood spots).

Conclusion


The hydrolysis-free SPLC-MS/MS assay enables rapid, accurate quantification of 19 opiates, opioids and their metabolites in urine. By pairing the Prelude SPLC system with TSQ Endura MS, analysts achieve high sensitivity, excellent precision and significantly reduced turnaround time, making it a valuable tool for forensic toxicology.

Reference


No external literature references were provided in the source document.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC-MS/MS for Forensic Toxicology
Direct Analysis of Opioids and Metabolites from Whole Blood Using Ostro Sample Preparation Plates Combined with UPLC-MS/MS for Forensic Toxicology Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA A P P L I…
Key words
opioids, opioidsblood, bloodmetabolites, metabolitesnorbuprenorphine, norbuprenorphineglucuronide, glucuronidetramadol, tramadolostro, ostrohole, holenormeperedine, normeperedineoxycodone, oxycodonefentanyl, fentanyldirect, directuplc, uplcpropoxyphene, propoxypheneopioid
Direct Analysis of Opioids and Metabolites in Oral Fluid by Mixed-mode μElution SPE Combined with UPLC-MS/MS for Forensic Toxicology
Direct Analysis of Opioids and Metabolites in Oral Fluid by Mixed-mode µElution SPE Combined with UPLC-MS/MS for Forensic Toxicology Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA A P P L I C…
Key words
oral, oralµelution, µelutionopioids, opioidsmetabolites, metabolitesfluid, fluidglucuronide, glucuronidemixed, mixedspe, spenorbuprenorphine, norbuprenorphinebuprenorphine, buprenorphinetramadol, tramadoldirect, directbias, biasuplc, uplcmode
Clinical research and forensic toxicology - Application Compendium
Endocrine Drugs of Abuse Pain Management Therapeutic Drug Analysis Clinical research and forensic toxicology Application Compendium Endocrine Analysis for Clinical Research* Therapeutic Drug Analysis for Clinical Research Drugs of Abuse Analysis for Forensic Toxicology** Pain Management Drug Analysis for Forensic…
Key words
scientific, scientificthermo, thermourine, urineprelude, preludemass, masssplc, splctsq, tsqafrica, africaturboflow, turboflowwere, werearea, areamethod, methodexactive, exactiveforensic, forensicsample
A Simplified, Mixed-Mode Sample Preparation Strategy for Urinary Forensic Toxicology Screening by UPLC-MS/MS
A Simplified, Mixed-Mode Sample Preparation Strategy for Urinary Forensic Toxicology Screening by UPLC-MS/MS Jonathan P. Danaceau, Erin E. Chambers, and Kenneth J. Fountain Waters Corporation, Milford, MA, USA A P P L I C AT I O N B E…
Key words
uplc, uplcpanel, paneline, ineforensic, forensiccompounds, compoundstramadol, tramadolalp, alptoxicology, toxicologycomprehensive, comprehensiveextraction, extractionbuprenorphine, buprenorphinepcp, pcpluc, lucacquity, acquityhin
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike